These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14361513)

  • 1. A source of error in the antenatal diagnosis of erythroblastosis; the importance of performing antibody tests early in pregnancy.
    BRANCATO GJ
    Am J Obstet Gynecol; 1955 Apr; 69(4):882-4. PubMed ID: 14361513
    [No Abstract]   [Full Text] [Related]  

  • 2. [Haemolytic disease of the newborn (fetus) (author's transl)].
    Fischer K; Poschmann A
    Immun Infekt; 1976 Dec; 4(6):249-60. PubMed ID: 828142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A note on decrease in avidity of the Coombs reaction by gradual elution of Rh antibodies from the sensitized cells.
    BARRIE J; KRIEGER VI
    Med J Aust; 1954 Feb; 41(1 7):247. PubMed ID: 13153544
    [No Abstract]   [Full Text] [Related]  

  • 4. [New theories on the subject of Rh factors and their practical application].
    DE KROMME L
    Ned Tijdschr Verloskd Gynaecol; 1953; 53(1):1-18. PubMed ID: 13099425
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contribution to the early diagnosis of erythroblastosis fetal by Rh factor].
    POHL J
    Dtsch Gesundheitsw; 1953 Mar; 8(10):304-5. PubMed ID: 13067751
    [No Abstract]   [Full Text] [Related]  

  • 6. Antenatal tests in the diagnosis and assessment of severity of haemolytic disease (Hd) of the fetus and newborn (hdn).
    Contreras M
    Vox Sang; 1994; 67 Suppl 3():207-10. PubMed ID: 7975494
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-invasive antenatal diagnosis.
    Gaudoin MR
    Lancet; 1993 Jul; 342(8862):54-5. PubMed ID: 8100327
    [No Abstract]   [Full Text] [Related]  

  • 8. Serological and prognostic significance of partial absorption anti-human globulin test for incomplete Rh antibodies.
    Srinivasan K; Bhatia HM
    Indian J Med Res; 1973 Mar; 61(3):402-5. PubMed ID: 4202050
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: Management of maternal isoimmunization.
    Med J Aust; 1974 Oct; 2(15):547-8. PubMed ID: 4214982
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prognosis of the probability of Rh conflict occurring and the prenatal diagnosis of the degree of severity of fetal hemolytic disease using a computer].
    Kuzin VF; Sidel'nikova VM
    Akush Ginekol (Mosk); 1978 Nov; (11):44-8. PubMed ID: 103454
    [No Abstract]   [Full Text] [Related]  

  • 11. [Our experience with the pre- and postnatal diagnosis of ABO-hemolytic disease of the newborn].
    Novachev D; Markov L; Antonov L; Tankov Ts
    Akush Ginekol (Sofiia); 1977; 16(5):317-26. PubMed ID: 413455
    [No Abstract]   [Full Text] [Related]  

  • 12. [Importance of determining Rh-antibodies and the dynamics of their titer in the blood of pregnant women for the diagnosis of Rh-conflict between mother and fetus].
    Umbrumiants DV
    Akush Ginekol (Mosk); 1970 May; 46(5):32-6. PubMed ID: 4991861
    [No Abstract]   [Full Text] [Related]  

  • 13. [Current status of neonatal hemolytic disease caused by Rh incompatibility].
    Uhlig R; Menzel K
    Z Arztl Fortbild (Jena); 1986; 80(4):143-8. PubMed ID: 3087070
    [No Abstract]   [Full Text] [Related]  

  • 14. [The prenatal diagnosis of hemolytic diseases due to Rh factors and the early termination of pregnancy].
    Kubli F
    Bibl Gynaecol; 1966; 38():30-62. PubMed ID: 4957983
    [No Abstract]   [Full Text] [Related]  

  • 15. Antenatal diagnosis of the Rh erythroblastotic fetus.
    RIGSBY WC; VORYS N; COPELAND WE; ULLERY JC
    Obstet Gynecol; 1961 Nov; 18():579-90. PubMed ID: 14492260
    [No Abstract]   [Full Text] [Related]  

  • 16. Fetal blood group determination in amniotic cells.
    Vázquez-Escobosa C; Pérez-Medina R; Ramos-Damián ME; Gómez-Estrada H
    Arch Invest Med (Mex); 1982; 13(2):101-4 passim. PubMed ID: 6808946
    [No Abstract]   [Full Text] [Related]  

  • 17. AMNIOCENTESIS FOR PRENATAL DIAGNOSIS OF ERYTHROBLASTOSIS FETALIS.
    QUEENAN JT; ADAMS DW
    Obstet Gynecol; 1965 Mar; 25():302-7. PubMed ID: 14268009
    [No Abstract]   [Full Text] [Related]  

  • 18. Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers.
    Lo YM; Bowell PJ; Selinger M; Mackenzie IZ; Chamberlain P; Gillmer MD; Littlewood TJ; Fleming KA; Wainscoat JS
    Lancet; 1993 May; 341(8853):1147-8. PubMed ID: 8097823
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis, prevention, and therapy in hemolytic disease of the newborn.
    Polesky HF
    Clin Lab Med; 1982 Mar; 2(1):107-22. PubMed ID: 6821161
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of the occurrence of erythroblastosis fetalis by antenatal Rh testing and its treatment by complete exchange transfusion.
    WIENER AS
    Pittsbg Med Bull; 1946 Nov; 35(39):778-86. PubMed ID: 20281084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.